world cancer report - iarc

5.106 & 5.107 IARC/SEER/Osaka Cancer Registry†
5.108 GLOBOCAN 2000*
5.109 Los Alamos National Laboratory/SPL/Cosmos
5.110 L.A.G. Ries, M.P. Eisner, C.L. Kosary, B.F. Hankey, B.A.
Miller et al., eds (2001) SEER Cancer Statistics Review,
1973-1998, National Cancer Institute, Bethesda MD, USA
5.111 A & B R.D. Brunning, Department of Laboratory Medicine and
Pathology, University of Minnesota Hospital, 420
Delaware Street S.E., Box 609, Minneapolis, MN 55455-
0385, USA
5.112 Adapted from a figure by J. Melo, Department of
Haematology, ISCM, Hammersmith Hospital, Ducane
Road, London W12 ONN, UK
5.113 A & B G. Flandrin, Laboratoire Central de Hématologie, Hôpital
Necker, 149 rue de Sèvres, F-75743 Paris, France
5.114 R.D. Brunning, Department of Laboratory Medicine and
Pathology, University of Minnesota Hospital, 420
Delaware Street S.E., Box 609, Minneapolis, MN 55455-
0385, USA
5.115 With permission of J.A. Squire, from V.D. Markovic,
D. Bouman, J. Bayani, J. Al-Maghrabi, S. Kamel-Reid et al.
(2000) Lack of BCR/ABL reciprocal fusion in variant
Philadelphia chromosome translocations: a use of double
fusion signal FISH and spectral karyotyping. Leukemia,
14(6):1157-1160
5.116 B. Hirsch, Department of Laboratory Medicine and
Pathology, University of Minnesota School of Medicine,
420 Delaware St. SE, Minneapolis, MN 55455, USA
5.117 J.W. Vardiman, Department of Pathology, University of
Chicago Medical Center, 5841 South Maryland Ave.,
MC0008 Romm TW-055, Chicago, IL 60637-1470, USA
5.118 IARC/SEER/Osaka Cancer Registry†
5.119 & 5.120 GLOBOCAN 2000*
5.121 Graphics and Audiovisual section, NCI Office of Cancer
Communications, USA
5.122 G. Zamboni, Dept of Pathology, University of Verona,
Strada Le Grazie, I-37134 Verona, Italy
5.123 G. Klöppel, Institute of Pathology, University of Kiel,
Michaelistrasse 11, D-24105 Kiel, Germany
5.124 P. Vogt, Department of Pathology, University Hospital
USZ, Schmelzbergstrasse 12, CH-8091 Zurich,
Switzerland
5.125 F. Berger and J.Y. Scoazec, Laboratoire d’Anatomo-
Pathologie, Hôpital Edouard Herriot, Place d’Arsonval,
69437 Lyon France
5.126 IARC/SEER/Osaka Cancer Registry†
5.127 GLOBOCAN 2000*
5.128 Data from New South Wales Central Cancer Registry†,
Australia
5.129 B.W. Stewart, Australia
5.130 - 5.134 W. McCarthy, Australia
5.135 GLOBOCAN 2000*
5.136 International Atomic Energy Agency, Vienna
5.137 GLOBOCAN 2000*
340 Sources of figures and tables
5.138 International Atomic Energy Agency, Vienna
5.139 F. Berger and J.Y. Scoazec, Laboratoire d’Anatomo-
Pathologie, Hôpital Edouard Herriot, Place d’Arsonval,
69437 Lyon France
5.140 Adapted from Figure 2, D.L. Learoyd , M. Messina,
J. Zedenius, B.G. Robinson (2000) Molecular genetics of
thyroid tumours and surgical decision making. World J
Surg, 24, 923-933
5.141 IARC/SEER/Osaka Cancer Registry†
5.142 & 5.143 GLOBOCAN 2000*
5.144 Wellcome Trust Medical Photographic Library, UK
5.145 B. Marincek, Institut für Diagnostische Radiologie,
UniversitätsSpital, Ramistrasse 100, CH-8091 Zurich,
Switzerland
5.146 Public Health Image Library, CDC, USA/Dr Edwin P. Ewing, Jr.
5.147 F. Berger and J.Y. Scoazec, Laboratoire d’Anatomo-
Pathologie, Hôpital Edouard Herriot, Place d’Arsonval,
69437 Lyon France
5.148 IARC/SEER/Osaka Cancer Registry†
5.149 J. Ferlay, F.I. Bray, R. Sankila, D.M. Parkin eds (1999)
EUCAN90: Cancer Incidence Mortality and Prevalence in
the European Union (IARC Cancer Bases No. 4), Lyon,
IARCPress
5.150 P. Kleihues, IARC
5.151 P.C. Burger, Pathology Building, Room 706, The Johns
Hopkins Hospital, 600 Wolfe Street, Baltimore, MD 21287,
USA
5.152 H. Ohgaki, IARC
5.153 P. Kleihues, IARC
5.154 A. Vital, Laboratory of Neuropathology, Victor Segalen
University, Bordeaux 2, 146, rue Leo-Saignat, 33076
Bordeaux, France
6.1 Wellcome Trust Medical Photographic Library, UK
6.2 - 6.5 G. Maddern, Australia
6.6 Varian Medical Systems, Palo Alto, USA
6.7-6.8 Varian Medical Systems UK Ltd.
6.9 & 6.10 Graphics and Audiovisual section, NCI Office of Cancer
Communications, USA
6.11 K. Sikora, UK
6.12 Modified from C.M. Haskell, ed (1995) Cancer Treatment,
4th Edition, W.B. Saunders/Reprinted from W.E. Ross et
al., Pharmacology and Therapeutics, copyright 1987, Vol.
32, p. 89, with permission from Elsevier Science
6.13 H. Stein, Institut für Pathologie, Freie Universität Berlin,
Universitätsklinikum Steglitz, Hindenburgdamm 30, D-
12200 Berlin, Germany
6.14 K. Sikora, UK
6.15 A. Villunger and A. Strasser (1999) The great escape: is
immune evasion required for tumor progression? Nat
Med, 5(8): 874-5
6.16 P. Hersey, Australia
6.17 K.R. Dumon, H. Ishii, L.Y. Fong, N. Zanesi, V. Fidanza et al.,
(2001) FHIT gene therapy prevents tumor development in Fhit-